OptimizeRx Corporation: financial analysis
Ratios worked out from 10 fiscal years of OptimizeRx Corporation's statements, compared with 30 companies in Healthcare Information Services.
OptimizeRx Corporation scorecard#
Passes 16 of the 24 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (3 of 6). Fiscal year 2025; market cap of Oct 20, 2026.
Valuation3 of 6
- ✗P/E below its peers' median35.9×P/E 35.9× against Healthcare's median of 29.9×.
- ✓Price to book below its peers' median1.3×Price to book 1.3× against Healthcare Information Services's median of 1.9×.
- ✗Price to sales below its peers' median1.7×Price to sales 1.7× against Healthcare Information Services's median of 1.7×.
- ✓Free cash flow yield above 5%11.3%Free cash flow is 11.3% of the market value.
- ✗Earnings yield above the 10-year Treasury yield2.8%Earnings yield 2.8% against the 10-year Treasury's 4.92% on 2026-11-20.
- ✓The price assumes slower growth than the last three years'13.6%The price assumes 13.6% a year for ten years; revenue grew 20.6% a year over the last three.
Growth6 of 6
- ✓Revenue grew in the newest year18.8%Revenue up 18.8% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years20.6%20.6% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median20.6%20.6% a year against Healthcare Information Services's median of 6.1% (27 companies).
- ✓Earnings per share grew in the newest year0.27 vs -1.10Diluted EPS 0.27 in fiscal 2025 against -1.10 the year before (report's currency).
- ✓Net income higher than five years earlier$5 M$5 M in fiscal 2025 against -$2 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability3 of 6
- ✓Profitable in the newest year$5 MNet income $5 M in fiscal 2025.
- ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median10.7%10.7% against Healthcare Information Services's median of -7.1% (29 companies).
- ✗Return on equity above 15%4.2%4.2% in fiscal 2025.
- ✗Return on invested capital above 10%6.4%6.4% in fiscal 2025.
- ✓Operating margin wider than three years earlier10.7%10.7% in fiscal 2025 against -19.7% in 2022.
Financial health4 of 5
- ✓Short-term assets cover short-term liabilities3.0×Current ratio 3.04 at the end of fiscal 2025.
- ✓Debt below equity0.2×Debt to equity 0.20 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDA0.2×Net debt 0.2 times EBITDA in fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone2.54Z-score 2.54 (grey zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year3.9%Diluted shares up 3.9% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Strengths
- Revenue has grown 15 years in a row.
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseyes
- Cash from operations exceeds profityes
- Long-term debt fell against assetsyes
- Current ratio roseyes
- No new shares issuedno
- Gross margin roseyes
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | 0.25 | × 1.2 | 0.29 |
| Retained earnings to assets | -0.45 | × 1.4 | -0.63 |
| Operating income to assets | 0.07 | × 3.3 | 0.22 |
| Market value to liabilities | 3.40 | × 0.6 | 2.04 |
| Revenue to assets | 0.62 | × 1 | 0.62 |
Where the return on equity comes from
The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.3% | 64.5% | 60.0% | 62.4% | 58.2% | 57.1% | 65% | |
| Operating margin | 10.7% | -14.9% | -36.9% | -19.7% | 0.6% | -7.1% | 82% | |
| Net margin | 4.7% | -21.8% | -24.6% | -18.3% | 0.6% | -6.8% | 79% | |
| Return on equity | 4.2% | -16.5% | -13.9% | -8.9% | 0.4% | -0.8% | 65% | |
| Return on assets | 3.0% | -11.3% | -11.1% | -8.3% | 0.4% | -2.6% | 72% | |
| Return on invested capital | 6.4% | — | — | — | — | — | — |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 18.8% | 28.8% | 14.5% | 1.9% | 41.5% | 8.7% | 86% | |
| Revenue growth, 3 years a year | 20.6% | 14.6% | 18.2% | 36.4% | 42.4% | 6.1% | 96% | |
| Revenue growth, 5 years a year | 20.4% | 30.2% | 27.5% | 38.8% | 51.2% | 12.4% | 77% |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | 0.20× | 0.29× | 0.30× | — | — | 0.62× | 83% | |
| Net debt | $3 M | $21 M | $24 M | — | — | $53 M | 57% | |
| Net debt to EBITDA | 0.18× | — | — | — | — | — | — | |
| Interest cover | — | — | -18.21× | — | — | — | — | |
| Current ratio | 3.04× | 2.89× | 3.04× | 11.74× | 12.28× | 2.61× | 69% | |
| Equity share of assets | 72.5% | 68.4% | 69.0% | 93.7% | 93.2% | 62.3% | 68% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $19 M | $5 M | $-7 M | $11 M | $1 M | $24 M | 45% | |
| Free cash flow margin | 17.1% | 5.2% | -10.3% | 16.9% | 1.0% | 14.1% | 60% | |
| Cash conversion | 364.9% | — | — | — | 192.1% | 304.9% | 73% | |
| Capital spending share of revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.7% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.63× | 0.52× | 0.45× | 0.45× | 0.61× | 0.59× | 57% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).